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Abstract: The guidelines for dietary cholesterol and/or egg intake for both the general
population and those at higher risk of cardiovascular disease (for example, people with
type 2 diabetes mellitus (T2DM)) differ between countries, and even for different specialist
societies in a country. The disparity between these guidelines is at least in part related to
the conflicting evidence as to the effects of eggs in the general population and in those with
T2DM. This review addresses the effect of eggs on cardiovascular disease (CVD) risk from
both epidemiological research and controlled prospective studies, in people with and without
cardio-metabolic disease. It also examines the nutritional qualities of eggs and whether they
may offer protection against chronic disease. The evidence suggests that a diet including
more eggs than is recommended (at least in some countries) may be used safely as part of
a healthy diet in both the general population and for those at high risk of cardiovascular
disease, those with established coronary heart disease, and those with T2DM. In conclusion,
an approach focused on a person’s entire dietary intake as opposed to specific foods or
nutrients should be the heart of population nutrition guidelines.
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1. Introduction
Despite our increased understanding of the pathophysiology of cardiovascular disease, there remains
uncertainty regarding the role of dietary cholesterol and eggs in its pathophysiology. The guidelines
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for dietary cholesterol and/or egg intake for both the general population and those at higher risk of
cardiovascular disease (for example, people with type 2 diabetes mellitus (T2DM)) differ between
countries, and even for different specialist societies in a country. For example, the National Heart
Foundation guidelines recommend that all Australians, including those with T2DM or metabolic
syndrome, restrict their egg intake to six eggs or fewer per week [1]; the British Heart Foundation and
Diabetes United Kingdom do not have a limit for dietary cholesterol or egg consumption [2]; and the
American Diabetes Association (ADA) until very recently had a limit on total cholesterol consumption
for both the general population and those with T2DM of 300 mg per day [3], with one egg containing
approximately 200 mg cholesterol. This guideline has since been changed and there is no longer a
limit on dietary cholesterol intake [4]. The American Heart Foundation and the American College of
Cardiology have also abolished their dietary cholesterol restrictions, but another group in the United
States, the National Lipid Association (NLA), has since revised their guidelines and is recommending
<200 mg per day of dietary cholesterol for those with dyslipidaemia [5–7]. The disparity between these
guidelines is at least in part related to the conflicting evidence as to the effects of eggs in the general
population and in those with T2DM. This review addresses the effect of eggs on cardiovascular disease
(CVD) risk from both epidemiological research and controlled prospective studies, in people with and
without cardio-metabolic disease. Cardio-metabolic risk refers to risk factors associated with increased
risk of cardiovascular disease and metabolic disease, and these two conditions are in turn related.
Metabolic disease or disorders include T2DM, insulin resistance, hypertension and dyslipidaemia. The
review also examines the nutritional qualities of eggs and whether they may offer protection against
chronic disease.
2. Epidemiological Evidence Suggesting That a High-Egg Diet is Safe for the General Population
but has Adverse Cardio-Metabolic Effects, Particularly in those with Diabetes Mellitus
Epidemiological studies to date have indicated very little association between a high egg intake and
cardiovascular disease or mortality in the general population; however, evidence suggests an adverse
effect in sub-groups of the population, notably in those with diabetes mellitus. A summary of each of the
epidemiological studies is provided in Table 1. Some of these studies of longer-term follow up or larger
sample size will be reviewed below in greater detail.
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Table 1. Summary of epidemiological evidence regarding egg consumption, cardiovascular disease, and incidence of diabetes.
Study Design
Association between Egg Consumption and
Cardiovascular Disease
Association between Egg Consumption
and Incidence of Diabetes
Framingham Study and
Offspring study [8,9]
24 year follow up of 912 and a prospective
cohort of 2879 American participants
No association between egg intake and
subsequent development of CHD
Intake of eggs associated with incidence
of type 2 diabetes with some dietary
pattern scores
Italian case-control study [10]
287 cases with AMI and 649 controls,
Italian women, conducted over 5 years
No association between egg consumption of
greater than 2 eggs/week and nonfatal
myocardial infarction
Not reported
Finnish Study [11]
14 year follow up of 5133 Finnish men and
women aged 30–69 years
No difference in egg consumption between
individuals who developed fatal coronary heart
disease and those who did not
Not reported
Oxford Vegetarian Study [12]
14 year follow up of 11,140 English
vegetarians and meat eating participants
>6 eggs/week associated with increased
mortality from ischemic heart disease
Not reported
Adventist Health Study [13]
6 year follow up of 34,192 vegetarian and
non-vegetarian American Seventh
Day Adventists
Consuming >2 eggs/week presents no
difference in risk of developing CHD compared
to consuming <1 eggs/week
Not reported
Nurses Health [14]
14 year follow up of 80,082 American
women aged 39–54 years
No association between consumption of up to 1
egg/day and risk of CHD or stroke; higher egg
consumption was associated with increased
CHD risk in people with diabetes
Not reported
Health Professionals
Follow-up [14]
14 year follow up of 37,851 American men
aged 40–75 years
No association between consumption of up to 1
egg/day and risk of CHD or stroke; higher egg
consumption was associated with increased
CHD risk in people with diabetes
Not reported
Japanese case-control
study [15]
660 cases with AMI and 1277 controls,
Japanese men and women aged 40–79 years
No association between egg intakes up to 4 or
more/week and incidence of AMI
Not reported
NIPPON DATA80 [16]
14 year follow up of 5186 women and 4077
men, all Japanese aged 30 years and over
No effect of egg consumption on risk of fatal
CHD events, stroke and cancer in men or
women consuming ě2 eggs/day; increased risk
of all cause mortality in women for ě1 egg/day
Not reported
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Table 1. Cont.
Study Design
Association between Egg Consumption and
Cardiovascular Disease
Association between Egg Consumption
and Incidence of Diabetes
Japan Public Health
Centre-based study [17]
21 year follow up of 90,735 Japanese male
and female participants aged 40–69 years
Total cholesterol levels were significantly
related to an increased risk of CHD, however
consumption of eggs almost daily was not
associated with CHD risk in middle-aged
Japanese men and women
Not reported
Greek EPIC diabetic
subgroup [18]
11 year follow up of 1013 Greek adults
with diabetes
Positive association with increased egg
consumption and cardiovascular mortality in
people with diabetes
Not reported
NHANES I [19]
20 year follow up of 9734 American adults
aged 25 to 74 years
No significant difference between consuming
>6 eggs/week compared to <1 egg/week in any
stroke, ischemic stroke or coronary artery
disease; consumption of >6 eggs/week was
associated with an increased risk of CHD in
people with diabetes
Not reported
Physician’s Health [20–22]
20 year follow up of 21,327 American male
participants aged 40 years and over and
36,295 American women aged 45 years
Egg consumption did not increase CVD risk,
but consumption of ě7/week was associated
with a 23% increased risk of all cause mortality
and in a separate study of the same cohort, a
28% increase risk of heart failure; consumption
of ď6 eggs/week did not increase the risk of
death from all causes
Men who ate 5–6 eggs/week had a 46%
higher risk of developing type 2 diabetes
than no eggs, and 58% higher for ě7
eggs/week; women who ate 2–4 eggs a
week had a 19% higher risk, and 77%
higher for ě7 eggs/week. In both groups,
there was a significantly increased risk of
developing type 2 diabetes with
increasing egg consumption
INTERHEART (A Global
Case-Control Study of Risk
Factors for Acute Myocardial
Infarction) [23]
Global study reporting on 5761 patients
who have had a heart attack and 10,646
controls free of heart disease, recruited over
4 years
Western dietary pattern (characterised by
higher intakes of fried foods, salty snacks and
meat) was shown to be associated with an
increased risk of heart attack; no association
between eggs and heart attack risk
Not reported
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Table 1. Cont.
Study Design
Association between Egg Consumption and
Cardiovascular Disease
Association between Egg Consumption
and Incidence of Diabetes
Atherosclerosis Risk in
Communities (ARIC) [24]
11 year follow up of 15,792 African
American and white American men and
women aged 45–64 years
23% increased risk of heart failure for each
extra serving of eggs/day, up to 7 eggs/week
Not reported
Insulin Resistance
Atherosclerosis Study [25]
Prospective cohort of 880 American
individuals with normal glucose tolerance
or impaired glucose tolerance
Not reported
High intake of a dietary pattern that
included eggs (as well as red meat, low
fibre bread and cereal, dried beans, fried
potatoes, tomato, vegetables, cheese and
cottage cheese, and low in wine) was
associated with developing type 2
diabetes
Cardiovascular health
study [26]
Prospective study of 3898 American older
adults (>65 years) followed for an average
of 11.3 years
Not reported
There was no association between egg
consumption or dietary cholesterol intake
and risk of developing type 2 diabetes
Health ABC Study [27]
9 year follow up of 1941 70–79 years old
Americans
Dietary cholesterol and consumption of ě3
eggs/week was associated with increased CVD
risk only in older adults with type 2 diabetes
(but not in those without type 2 diabetes)
Not reported
NHANES III [28]
9 year follow up of 20,050 American adults
(17 years and over)
No association between egg intake (>7/week
compared to <1/week) and CHD mortality
Not reported
Chinese cohort study [29]
Data from 2849 Chinese adults (20 years
and over)
Not reported
Egg consumption was significantly and
positively associated with diabetes risk.
The OR of diabetes associated with egg
consumption <2/week, 2–6/week, and
ě1/day in the total sample were 1.00,
1.75, 2.28 respectively. These
associations were stronger in women
compared to men
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Table 1. Cont.
Study Design
Association between Egg Consumption and
Cardiovascular Disease
Association between Egg Consumption
and Incidence of Diabetes
The SUN Project [30]
6 year follow up of 14,185 Mediterranean
university students
No association between egg consumption and
the incidence of CVD for the highest (>4
eggs/week) versus the lowest (<1 egg/week)
category of egg consumption
Not reported
Case-control study [31]
234 Lithuanians aged 35–86 years with a
newly confirmed diagnosis of type 2
diabetes according to WHO criteria, and
468 controls
Not reported
Participants who consumed >5
eggs/week had a higher risk (threefold)
of type 2 diabetes than those who
consumed <1 egg/week
Malmo Diet and Cancer
Cohort [32]
Prospective cohort including 27,140
Swedish participants (45–74 years) during a
12 year follow up
Not reported
Highest quintiles of egg intake associated
with increased risk of developing type 2
diabetes
Mediterranean cohort—the
SUN project [33]
Prospective cohort of 15,956 participants
from Spanish population (average age 38.5
years) during 6.6 years (median) follow up
Not reported
Egg consumption was not associated
with the development of diabetes,
comparing the highest (>4 eggs/week)
with the lowest (<1 egg/week) quartile of
egg consumption
The Northern Manhattan
Study [34]
1429 American adults with carotid
ultrasounds followed for 11 years
Egg consumption was inversely associated with
carotid intima media thickness. For every
additional egg consumed/week, risk of plaque
decreased by 11%
Not reported
The Kuopio Ischaemic Heart
Disease Risk Factor Study [35]
2332 men from Finnish population (42–60
years) during 19.3 years follow-up
Not reported
Higher egg intake was associated with a
38% lower risk of developing type 2
diabetes compared to those in the lowest
group of egg intake
Nutrients 2015, 7 7405
Table 1. Cont.
Study Design
Association between Egg Consumption and
Cardiovascular Disease
Association between Egg Consumption
and Incidence of Diabetes
Meta-Analysis/Systematic Review regarding egg consumption, cardiovascular disease, and incidence of diabetes
Cardiovascular diseases and
diabetes meta-analysis [36]
14 studies (320,778 participants):11
prospective, 1 case-control and 2
cross-sectional studies. Sample size ranged
from 488 to 117,943. Follow-up time from
6.1 to 20 years
Positive dose-response association between egg
consumption and risk of CVD. A 19%
increased risk of CVD in highest egg
consumption compared to lowest egg intake. A
sub group (participants with diabetes) found to
have a further increased risk of CVD (RR 1.83)
There was a dose-response positive
association between egg consumption
and risk of diabetes
Dose-response meta-analysis of
prospective cohort studies [37]
8 articles with 17 reports (9 for CHD and
8 for stroke)
No significant association found between egg
consumption up to 1 egg/day and risk of CHD
or stroke. In a subgroup analysis of people with
diabetes, higher egg consumption (up to 1
egg/day) associated with a higher risk of CHD
but lower risk of haemorrhagic stroke
Not reported
Cardiovascular disease and
diabetes systematic review and
meta-analysis [38]
22 independent cohorts from 16 studies.
Number of participants ranged from 1600
to 90,735. Follow-up time ranged from 5.8
to 20 years
Consuming ě1 egg/day was not associated
with risk of overall CVD, ischemic heart
disease, stroke or mortality. In a subgroup
population (people with diabetes), those who
ate eggs >once a day were 1.69 times more
likely to develop CVD co-morbidity
Those who ate ě1 egg/day (compared to
those who never ate eggs) were 42%
more likely to develop type 2 diabetes
Tran et al. systematic
review [39]
8 epidemiological studies that examined the
risk of developing type 2 diabetes mellitus.
6 of the studies evaluated egg consumption,
whilst 2 of the studies evaluated dietary
patterns that included eggs
Not reported
4 of the 8 studies found a significant
association between diabetes risk and egg
consumption.
Abbreviations: ABC, ageing and body composition; AMI, acute myocardial infarction; ARIC, atherosclerosis risk in communities; CHD, coronary heart disease;
CVD, cardiovascular disease; EPIC, European prospective investigation into cancer and nutrition; NHANES, national health and nutrition examination survey; OR,
odds ratio; RR, relative risk.
Nutrients 2015, 7 7406
Earlier evidence as to the effect of egg intake on cardio-metabolic outcomes comes from the
Framingham study (follow up of 24 years), which aimed to determine factors related to the development
of cardiovascular disease. In doing so it addressed the effect of dietary intake (including egg
consumption) on circulating cholesterol levels and on the incidence of coronary heart disease in a free
living population in Framingham, MA, USA [8]. Egg intake in this population ranged from 0 to 24
eggs per week in males and from 0 to 19 per week in females, with an average egg consumption
of 5.9 per week for males and 3.8 per week for females. Results showed no significant association
between the number of eggs consumed with all-cause mortality, total coronary heart disease, myocardial
infarction, or angina pectoris. Furthermore, a low versus high egg consumption had no effect on blood
cholesterol level. This finding supported the data from intervention studies conducted at the same
time (late 1970s) showing no effect of egg feeding in the general population [40–42]. Importantly,
the Framingham study also suggested that focus should be placed on a person’s entire dietary intake
rather than egg or cholesterol intake alone, because circulating cholesterol distribution curves of the
subjects according to tertiles of egg or cholesterol intake were more or less identical. This study has been
supported by several other large epidemiological studies conducted later. Hu and colleagues reported on
egg consumption and risk of cardiovascular disease in two large prospective cohort studies examining
both males from the Health Professionals Follow-up Study (n = 37,851) and females from the Nurses’
Health Study (n = 80,082) [43]. Both studies found a decline in the average egg consumption from
2.3 per week in 1986 to 1.6 eggs per week in 1990 for males, and a decline from 2.8 eggs per week
in 1980 to 1.4 eggs per week in 1990 for females. This coincided with the increased emphasis in the
USA during that same period [44,45], to restrict dietary cholesterol intake to less than 300 mg per
day and limit egg consumption due to the high dietary cholesterol content of eggs. Egg consumption
(one egg per day) had no significant association with nonfatal myocardial infarction or mortality from
coronary heart disease, or risk of total stroke or its subtypes, whether or not subjects with diabetes
or hypercholesterolemia were included in the analyses [43]. However, when examining subgroups of
the population, a positive association between a higher egg intake and relative risk of coronary heart
disease was found for those with diabetes [43]. Results were similar in the Physicians Health Study
(n = 21,327), in that egg consumption (<7/week) was not associated with myocardial infarction, stroke
or total mortality in male physicians [21]. However, consumption of greater than or equal to seven
eggs per week was associated with a greater risk of mortality for this entire cohort of male physicians.
This positive correlation to mortality with a higher intake of eggs (ě7 eggs/week) was evident more
so in those with diabetes [21]. At the time when the Physicians Health Study was conducted (as well
as the majority of the other epidemiological studies), a public health campaign (which was emphasised
in the early 1980s) was advising people to limit their cholesterol intake (including their consumption
of eggs) [44,45]. Individuals (particularly physicians) consuming a high number of eggs during that
time may have been less likely to have been following healthy dietary and lifestyle advice in general.
Indeed, in this study [21], male physicians consuming a higher intake of eggs were also following other
unhealthy behaviours including reduced frequency of exercise and increased smoking, and had a higher
prevalence of diabetes and hypertension [21].
Epidemiological data from studies conducted in Japan [15–17], Italy [10] and Finland [11] and
systematic and meta-analytic reviews [37,38] also support the above-mentioned data from the United
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States (Framingham Study [8], Health Professionals Follow-up Study, Nurses’ Health Study [43]) as well
as data from other United States studies listed in Table 1 [13,19,28], in that egg consumption showed
no significant association with the risk of coronary heart disease or cardiovascular heart disease in the
general population. However, again, as seen with some studies conducted in the United States [21,27,43],
this result was not consistent when analysing sub-groups of the population, such as in those with
self-reported diabetes [17,18]. With respect to egg consumption and incidence of diabetes, again there
are inconsistencies. Despite most studies suggesting an increased association of diabetes incidence and
egg consumption [20,29,31,32,36,38], some studies show no association between egg consumption and
risk of developing T2DM [26,33], with one study even showing a higher egg intake being associated
with a 38% lower risk of developing T2DM [35].
While the above-mentioned studies show no overall effect of eggs on CVD (at least up to an intake
of six eggs per week), and an increased incidence of T2DM with increased egg consumption, when
considering stroke, some of these epidemiological studies have shown a significant inverse relationship
between a high egg consumption and reduced risk of total and haemorrhagic stroke, and stroke
mortality [19,28,46]. This data provides circumstantial and weak evidence that eggs may have protective
effects against certain pathologies.
In summary, there are inconsistencies in the findings between these prospective cohort studies in terms
of the risk of CVD and mortality, and incidence of diabetes mellitus. Most studies show no association
between egg consumption and CVD risk in a healthy population [8,10,11,13,17,19,28,30,34,47], while
others suggest an increased risk of CVD with higher egg consumption (ě7 eggs per week) [12,16,21,24].
With respect to the incidence of diabetes with egg consumption, most studies suggest an increased
association of diabetes incidence and egg consumption [20,29,31,32,36,38], some studies show no
association between egg consumption and risk of developing T2DM [26,33], and one study shows a
protective effect of higher egg intake and incidence of T2DM [35]. Conversely, the risk of stroke appears
to be lower with higher egg consumption [19,28,46]. Similar discrepant findings are seen in subgroups of
the population and specifically in people with diabetes mellitus, with some studies showing no increased
risk in CVD with egg consumption [8,17,28,35], but the majority suggesting that a higher egg intake
(usually ě7 eggs per week) may increase the risk of CVD in this group [18,19,21,27,43]. An important
limitation of these epidemiologic studies in general is the presence of confounding factors that have
a known effect on coronary artery disease and cardiovascular heart disease that may not have been
accounted for. Despite adjusting for some confounding factors in statistical models in the Physicians
Health Study, detailed dietary data (total energy intake and saturated fat) and other important variables
(markers of insulin resistance and lipids) that predict the onset of cardiovascular disease were not taken
into account [21]. Intake of energy, total fat, fruit or wholegrains, as well as body mass index and family
history, were only controlled for in a minority of the above-mentioned epidemiological studies [28,43].
These limitations highlight the need for controlled, prospective studies to determine the impact of eggs
per se on cardio-metabolic health. Importantly, it is now known that dietary cholesterol is not the
principal factor affecting circulating cholesterol levels, with the main determining dietary factors being
saturated and trans-fat intake [48,49], for which only one [28] of these epidemiological studies adjusted.
In this study that adjusted for saturated fat intake [28], there was no increased risk of coronary heart
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disease mortality or stroke in those eating greater than six eggs per week compared to those eating one
to six eggs per week.
3. Controlled Prospective Studies of the Effects of a High Egg Diet on Dietary Cholesterol Intake
and Circulating Cholesterol Levels
3.1. The Relationship between Dietary and Circulating Cholesterol
The effect of dietary cholesterol intake on circulating cholesterol level is small. A meta-analysis of
cholesterol feeding studies including both healthy populations and populations with cardio-metabolic
disease, using a variety of sources of dietary cholesterol (including eggs) showed that for every
100 mg per day increase in dietary cholesterol intake, circulating total cholesterol increased by
0.06 mmol/L, high-density lipoprotein (HDL) increased by 0.008 mmol/L, and the ratio of total to
HDL cholesterol increased by 0.020 [50]. One large egg contains approximately 200 mg of dietary
cholesterol, so consuming an egg a day would be expected to increase total circulating cholesterol
levels by approximately 0.12 mmol/L [50]. While mean changes in lipoproteins in response to dietary
cholesterol are small, considerable heterogeneity has been observed in circulating cholesterol responses
to dietary cholesterol [51]. For example, there appears to be less efficient absorption of dietary
cholesterol in those who have obesity and insulin resistance, when compared to those who are lean and
insulin sensitive [52,53]. However, meta-analyses comparing the effects of dietary cholesterol and fat
on circulating lipid and lipoprotein levels reveal that dietary saturated and trans-fat elicit much stronger
effects, and taking into consideration their higher percentage energy contribution in the diet relative to
dietary cholesterol, saturated and trans-fat are the major contributors to circulating total and low-density
lipoprotein (LDL) cholesterol levels [48,49,54]. For every 2.8-gram per day reduction in saturated fat
intake, total cholesterol reduces by approximately 0.08 mmol/L. Therefore, while increasing egg intake
by one egg per day would be expected to increase total cholesterol by approximately 0.12 mmol/L, a
concomitant reduction in saturated fat intake by 6 g per day (the amount of saturated fat in a tablespoon
of butter, for example) would be expected to reduce circulating cholesterol levels by a similar amount.
3.2. Studies Conducted in the General Population
Prospective controlled studies conducted in the general population (that is, in those that are relatively
healthy without cardio-metabolic disorders) have shown differing effects of egg consumption on CVD
risk. There have been numerous cholesterol feeding studies conducted in a free-living general population
over the last 50 years and some of these studies are referenced in the following section. However, a
summary of only those controlled prospective studies conducted in the general population since the
meta-analytic review performed by Weggemans and colleagues [50] is provided in Table 2.
In some studies in which additional cholesterol (in the form of eggs) has been added to peoples’ diet
under strict control, there have been increases in circulating total and LDL cholesterol noted [55–57],
whilst in other such studies there have been no changes [40–42,58–60]. In some studies, circulating HDL
cholesterol levels significantly increased with the addition of eggs to the diet [61–63], which was also
found in the meta-analytic review of dietary cholesterol feeding in 556 subjects from 17 heterogeneous
studies using both eggs and high cholesterol products [50]. However, in that review the authors reported
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the adverse coronary risk finding of an increase in the ratio of total to HDL cholesterol by 0.02 units [50].
The majority of these studies (15 of 17 of them) involved subjects from an otherwise healthy population
without metabolic disorders, but one study included those with type 1 diabetes mellitus (T1DM) and
another included subjects with hypercholesterolemia and hyperlipidaemia. While there was a small but
statistically significant adverse change in the total to HDL cholesterol ratio overall, five of the 17 studies
showed no adverse effects of cholesterol feeding on the lipid profile, six studies showed equivocal effects,
and only six studies showed adverse effects. More importantly, this change in lipid profile appeared to be
dependent on the quality of the diet prescribed, or background diet of the population group [50,64,65].
This meta-analytic review [50] found that in subjects who were fed a high cholesterol diet and who had a
background diet that was low in saturated fats (a polyunsaturated to saturated fat ratio > 0.7), the increase
in LDL cholesterol was less apparent than in those studies in subjects in whom the background diet
was high in saturated fats (a polyunsaturated to saturated fat ratio ď 0.7) [50]. Thus, these observations
suggest that a person consuming a higher dietary cholesterol diet in the context of a diet lower in saturated
fat is unlikely to experience any adverse effect on circulating lipids.
Table 2. Effect of egg consumption on cholesterol levels in the general population.
Reference Study Details Cholesterol/Egg Intake
Effect on Lipids from High Cholesterol or
Egg Intake
Greene et al.
2005 [66]
42 healthy
postmenopausal
women and men
> 60 years
3 eggs/day for 1 month
(compared to egg substitute)
LDL and HDL cholesterol levels increased;
LDL:HDL and TC:HDL ratios did
not change
Katz et al.
2005 [67]
49 healthy adults
2 eggs/day for 6 weeks
(compared to oats breakfast)
No effect on total cholesterol or
endothelial function
Goodrow et al.
2006 [68]
33 adults > 60 years
1 egg/day for 5 weeks
(compared to egg substitute)
No increase in total cholesterol, LDL
cholesterol or HDL cholesterol levels
Harman et al.
2008 [69]
45 overweight or
obese adults
(18–55 years)
2 eggs/day as part of an energy
restricted weight loss diet
(compared to no eggs/day)
Decreased total and LDL cholesterol
Mutungi et al.
2008 [61]
28 overweight or
obese men
(40–70 years)
3 eggs/week as part of a CHO
restricted weight loss diet
(compared to egg substitute)
Increased HDL cholesterol; no change in
LDL cholesterol levels
Rueda et al.
2013 [70]
73 university students
Breakfast with eggs 5
times/week for 14 weeks
(compared to breakfast without
eggs)
Egg breakfast contained 400mg
more cholesterol than the
breakfast without eggs
No significant differences in total, LDL
cholesterol or HDL cholesterol between the
two groups
Clayton et al.
2015 [71]
25 healthy young
adults (18–35 years)
2 eggs per day (compared to a
bagel breakfast) for 12 weeks
No impact on total cholesterol, HDL
cholesterol or LDL cholesterol levels
The egg breakfast led to improvements in
triglyceride levels
Abbreviations: CHO, carbohydrate; HDL, high density lipoprotein; LDL, low density lipoprotein; TC,
total cholesterol.
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Of the more recent studies completed (Table 2), five of the seven studies have shown no adverse
effects on the lipid profile following a high egg intake [66–68,70,71] and two have shown improvements
in circulating lipids with an increased egg consumption [61,69].
3.3. Studies Conducted in people with High Risk of Cardiovascular Disease, Established Coronary
Heart Disease, or with Diabetes Mellitus
In contrast to the variable effects of cholesterol feeding on circulating lipid profiles in the general
population (that is, in those that are otherwise healthy and without cardio-metabolic disorders), with
some studies showing an increase in the ratio of total to HDL cholesterol and LDL cholesterol, but
others showing no adverse effects, in people with a high risk of cardio-metabolic disease the effects of
a high egg diet appear generally positive. As there has been only a small number of well-designed
studies conducted in such a population (that is, in people with high risk of cardiovascular disease
or T2DM, established coronary heart disease, or with diabetes mellitus), these will be reviewed in
greater detail. Six of these studies have been conducted in individuals at high risk of cardiovascular
disease or T2DM [52,53,72–78], one in those with established coronary heart disease [79], and three in
those with T2DM [80–82]. Of these, three studies have shown beneficial effects of a high egg diet on
cardio-metabolic risk factors with respect to the comparator or control group [72–75,81,82], five have
shown no adverse effect [53,76,78–80], and two have shown a detrimental effect, but only in sub-groups
of the population being investigated [52,77]. A summary of each of the controlled prospective studies
conducted in people with cardio-metabolic disease is provided in Table 3.
Table 3. Effect of egg consumption on cholesterol levels in those with cardio-metabolic
disease, including type 2 diabetes mellitus.
Reference Study Details Cholesterol/Egg Intake
Effect on Lipids from Increased
Cholesterol or Egg Intake
Edington et al.
1987 [76]
168 adults with
hyperlipidaemia
2 eggs/week or 7 eggs/week
as part of a low fat, high fibre
diet for 8 weeks
No change to total, LDL or
HDL cholesterol
Knopp et al.
1997 [77]
161 adults with
hypercholesterolemia or
hyperlipidaemia
2 eggs/day as part of an
American Heart Association
diet for 6 weeks
Increased LDL and HDL
cholesterol levels;
Adults with only high cholesterol had
only non-significant increases in
LDL cholesterol
Knopp et al.
2003 [52]
197 adults with insulin
resistance
4 eggs/day for 4 weeks
Increased LDL cholesterol;
This increase in LDL cholesterol
was less in insulin resistant
individuals compared to insulin
sensitive individuals
Tannock et al.
2005 [53]
201 lean insulin-sensitive
adults and lean or obese
insulin resistant adults
4 eggs/day as part of a low
fat diet for 4 weeks
HDL cholesterol increased in all
subjects; non HDL cholesterol
levels increased in lean
insulin-sensitive subjects but not
insulin-resistant subjects
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Table 3. Cont.
Reference Study Details Cholesterol/Egg Intake
Effect on Lipids from Increased
Cholesterol or Egg Intake
Njike et al.
2010 [78]
40 adults with hyperlipidemia
3 and then 2 eggs/day (acute
and sustained phase) for 6
weeks (compared to
sausage/cheese breakfast
sandwich and egg substitute)
No change to total, LDL or HDL
cholesterol. No detrimental effects
on flow mediated dilatation
Pearce et al.
2011 [81]
65 adults with type 2 diabetes
or impaired glucose tolerance
2 eggs/day as part of an
energy restricted, high
protein diet for 12 weeks
(compared to animal protein
substitute)
Increased HDL cholesterol levels
Blesso et al.
2013 [73–75]
and Andersen
et al. 2013 [72]
37 adults with metabolic
syndrome
3 eggs/day as part of
carbohydrate restricted diet
for 12 weeks (compared to
egg substitute)
No change in total or LDL
cholesterol; Increased HDL
cholesterol; Increased LDL
particle size
Fuller et al.
2015 [80]
140 overweight or obese
adults with impaired glucose
tolerance or type 2 diabetes
2 eggs/day for 6 days/week
as part of a 3 month weight
maintenance diet (compared
to <2 eggs/week)
No difference in change in HDL
cholesterol, total cholesterol or
LDL cholesterol levels between the
two groups
Katz et al.
2015 [79]
32 adults with CAD 2 eggs/day for 6 weeks
Daily consumption of eggs showed
no adverse effects on total cholesterol
levels compared to a
high-carbohydrate breakfast
Abbreviations: CAD, coronary artery disease; HDL, high density lipoprotein; LDL, low density lipoprotein.
In a study investigating the effect of high egg intake (three eggs per day) versus egg substitute (which
is comprised of 99% egg white and contains no cholesterol or fat) in those with metabolic syndrome,
improvements in dyslipidemia were noted for both groups when accompanied by a three-month
weight reduction program. However, reductions in circulating concentrations of the inflammatory
markers tumour necrosis factor alpha (TNF-α) and serum amyloid A (a protein secreted in response
to inflammatory stimuli) only occurred in the egg group [74]. Thus the high egg diet had a beneficial
effect in reducing inflammation in this population with metabolic syndrome.
One study has been conducted in people with established coronary heart disease, and in contrast
to the majority of studies, the primary outcome was endothelial function, assessed by flow-mediated
dilatation. The authors found no difference in flow-mediated dilatation or circulating lipid levels between
subjects that were following a high egg diet of two eggs per day compared to those following a high
carbohydrate breakfast or a breakfast containing egg substitute [79]. One other study in which subjects
with hyperlipidaemia were prescribed three eggs during the acute phase and two hard-boiled eggs during
the sustained phase for breakfast along with their habitual diet, found no detrimental effects on flow
mediated dilatation or lipid profile when compared to baseline levels [78].
In an earlier study in those with either hypercholesterolemia or hyperlipidaemia, subjects followed
the National Cholesterol Education Program (NCEP) Step I Diet for six weeks before being randomised
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to 2 eggs or egg substitute daily [77]. There was no difference between the hypercholesterolemia or
hyperlipidaemia egg fed groups for change in LDL cholesterol, when compared to a control group not fed
eggs. However, the authors also reported on within group changes and found that there were significant
increases in LDL cholesterol relative to baseline in the hyperlipidaemic egg fed group, and significant
increases in HDL cholesterol in both the hypercholesterolemia and hyperlipidaemic egg fed groups from
baseline to 12 weeks [77]. However, an important limitation of this study is that the group on the high
egg diet also had a significantly higher intake of saturated fat compared to the control group not fed
eggs [77].
There have been only three controlled, prospective studies investigating the effects of a high egg diet
specifically in people with T2DM, and only one study in people with T1DM [83]. This short-term study
over three weeks examined cholesterol feeding in both subjects with and without T1DM. There was an
increase in the ratio of LDL to HDL cholesterol over a three-week period for those with T1DM only when
800 mg of cholesterol was added to their diet daily (as a liquid supplement containing egg yolk) [83].
One of the studies conducted in subjects with T2DM was accompanied by a weight loss prescription,
which may have counteracted any potential detrimental effects of eggs on cardiovascular markers. In
that study, there was no difference in LDL cholesterol between the high (two eggs per day) and no egg
diet groups, and those on a high egg diet had a significant increase in HDL cholesterol compared to the
no egg diet [81]. The other two studies were conducted under weight maintenance conditions. Over the
course of a three-month weight maintenance study examining the effects of a high (12 eggs per week)
versus low-egg (<2 eggs per week) diet [80] in those with impaired glucose tolerance or T2DM, the
findings were similar to those reported by Pearce et al. in their weight loss study [81]. During this study
subjects were required to maintain their weight and activity level, with an emphasis placed on replacing
saturated fat with poly- and mono-unsaturated fatty acids in the diet. No adverse changes in circulating
lipid profiles were evident when compared to those following a low egg diet [80]. Lastly, in a study
comparing the consumption of one egg per day for breakfast versus an oatmeal-based breakfast in those
with T2DM, there was no difference in fasting plasma glucose between groups after a five-week period.
Similarly to the study in subjects with metabolic syndrome [74], there was a significant reduction in the
inflammatory marker TNF-α in the one egg per day group [82].
Thus, apart from one small study of short duration (three weeks) which showed an increase in the
ratio of LDL to HDL cholesterol with the addition of 800 mg dietary cholesterol daily in people with
T1DM, all other studies conducted to date in subjects with cardio-metabolic disease or T2DM, have
shown either a positive or no adverse effect on cardiovascular risk factors from a high egg diet.
4. Positive and Negative Nutritional Qualities of Eggs
Eggs are very high in dietary cholesterol, and despite an increase in circulating LDL cholesterol levels
seen in some but not all dietary cholesterol feeding studies, eggs do possess nutritional benefits that may
have benefits on health outcomes and CVD risk.
Eggs contain carotenoids (lutein and zeaxanthin) recognised for their role in protecting against
age-related macular degeneration and cataracts, as well as for their antioxidant and anti-inflammatory
properties [75,84]. They provide arginine (a precursor to nitric oxide), which in turn causes blood vessels
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to dilate, thereby playing a key role in endothelial function [85], and folate, which may reduce the risk
of T2DM and cardiovascular disease [86,87], and risk of neural tube defects during pregnancy [88].
Omega-3 fortified eggs may also serve a role in the diet, particularly for people with
hypertriglyceridemia and those who avoid fish. Two studies have shown consumption of omega-3
supplemented eggs to be associated with a significant decrease in circulating triglycerides [89,90],
consistent with the improvements in triglyceride levels seen with fish or fish oil consumption [91,92].
Eggs are a substantial source of choline, which is a known neurotransmitter involved in cognitive
function [93], but dietary phosphatidylcholine is associated with the production of a proatherosclerotic
metabolite, trimethylamine-N-oxide (TMAO) in a gut-flora dependent manner, and this has been
associated with an increased risk of cardiovascular events [94]
However, to date the effect of long term egg intake on TMAO levels has not been assessed. Thus
despite the potential for an adverse effect of the cholesterol in eggs on LDL cholesterol, it is conceivable
that specific components of eggs could also contribute to favourable health outcomes and reduced CVD
risk in people who consume a high egg diet. When eggs are included in the context of a healthy diet, these
nutritional benefits could conceivably outweigh any adverse effects of eggs, albeit further well-controlled
studies are required to test this.
5. Conclusions
Despite conflicting guidelines between countries regarding dietary cholesterol and specifically egg
intake, the evidence suggests that a diet including more eggs than is recommended (at least in some
countries) may be used safely as part a healthy diet in both the general population and for those at
high risk of cardiovascular disease, those with established coronary heart disease, and those with type 2
diabetes mellitus. The background or intervention diet appears to be a key nutritional component. A high
egg diet in the context of a background diet that is low in saturated fats (a polyunsaturated to saturated fat
ratio > 0.7), or a diet that replaces saturated fats with poly- and mono-unsaturated fats, is likely to result
in positive or no adverse changes in LDL cholesterol, and could be safely advised. Hence, an approach
focused on a person’s entire dietary intake as opposed to specific foods or nutrients should be the heart
of population nutrition guidelines.
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